WaaL is an inner membrane glycosyltransferase that catalyzes the transfer of O-antigen polysaccharide from its lipid-linked intermediate to a terminal sugar of the lipid A-core oligosaccharide, a conserved step in lipopolysaccharide biosynthesis. Ligation occurs at the periplasmic side of the bacterial cell membrane, suggesting the catalytic region of WaaL faces the periplasm. Establishing the membrane topology of the WaaL protein family will enable understanding its mechanism and exploit it as a potential antimicrobial target. Applying oxidative labeling of native methionine/cysteine residues, we previously validated a topological model for Escherichia coli WaaL, which differs substantially from the reported topology of the Pseudomonas aeruginosa WaaL, derived from the analysis of truncated protein reporter fusions. Here, we examined the topology of intact E. coli and P. aeruginosa WaaL proteins by labeling engineered cysteine residues with the membraneimpermeable sulfhydryl reagent polyethylene glycol maleimide (PEG-Mal). The accessibility of PEG-Mal to targeted engineered cysteine residues in both E. coli and P. aeruginosa WaaL proteins demonstrates that both ligases share similar membrane topology. Further, we also demonstrate that P. aeruginosa WaaL shares similar functional properties with E. coli WaaL and that E. coli WaaL may adopt a functional dimer conformation.
Introduction
The Gram-negative bacterial cell envelope comprises an outer and an inner membrane separated by the periplasmic space. The lipopolysaccharide (LPS), a glycolipid made of lipid A, core oligosaccharide (core) and O-antigen (OAg) polysaccharide (Valvano, 2011) , is a predominant component of the outer membrane. LPS helps maintain the stability and relative impermeability of the outer membrane. The lipid A provides a scaffold for the assembly of the core via sequential sugar transfer reactions. The lipid A-core is further remodeled by chemical modifications that provide bacteria with resistance to cationic antimicrobial peptides and hydrophobic antibiotics, contributing to bacterial evasion of innate immune recognition and intrinsic antimicrobial resistance (Needham and Trent, 2013) .
OAgs are polymers of sugar repeating units that vary greatly in chemical composition, structure and antigenicity across individual strains and bacterial species (Knirel, 2011) . Bacteria expressing OAg resist innate immune attack by host macrophages and serum complement (Pluschke and Achtman, 1984; Joiner, 1988) . OAgs are independently assembled as undecaprenyl-pyrophosphate (Und-PP)-linked saccharides and ligated to the lipid A-core (Valvano, 2011) resulting in the release of Und-PP, which is recycled into Und-P by a poorly characterized pathway. Und-P is essential for the biosynthesis of other surface polymers such as capsules and cell wall peptidoglycan (Valvano, 2011) . All these processes occur in the inner membrane and require the activities of membrane-embedded proteins that participate in various key steps of lipid A-core and OAg assembly (Valvano, 2011) . LPS export from the inner to the outer membrane and the proper insertion of LPS in the outer leaflet of the outer membrane require Lpt proteins, which form a trans-cell envelope multiprotein complex spaning the inner and outer membranes (Okuda et al., 2016; Sperandeo et al., 2017) .
Und-PP-linked OAgs appearing on the periplasmic side of the membrane become ligated to preformed lipid A-core (Valvano, 2011) . The membrane protein WaaL catalyzes the ligation step that joins the OAg to the rest of the LPS. WaaL can specifically recognize one or more terminal sugars of the lipid A-core acceptor (Feldman et al., 1999) , but shows no specificity for the structure of the lipid-linked saccharide substrate (Heinrichs et al., 1998c) . Therefore, despite different OAgs can be recombinantly expressed in Escherichia coli distinct WaaL proteins cannot cross-complement an E. coli K-12 waaL mutant . The periplasmic location of the ligation reaction suggests that potential inhibitory molecules need not enter into the bacterial cytosol and could evade membrane drug efflux mechanisms, which reduces A. Cartoon representation of in silico topology models of WaaL proteins from E. coli and P. aeruginosa (WaaL Ec -TMHMM and WaaL Pa -TMHMM, respectively), which were obtained with TMHMM (Sonnhammer et al., 1998) . Also shown is a cartoon representation of the topology model of P. aeruginosa WaaL (WaaL Pa -Del/Fus) obtained from the analysis of phoA-lacZα dual-reporter fusions (Islam et al., 2010) . Numbers next to each predicted transmembrane helix indicate the position of amino acid residues at the predicted boundaries between soluble and membrane (TMH) embedded regions. TMHs are indicated by roman numerals. Shaded TMHs in WaaL Pa -Del/Fus denote helices that show major differences with in the WaaL Pa -TMHMM model. PL, periplasmic loop; CL, cytoplasmic loop. Purple stars symbolize the location of known functional residues in WaaL Ec (Pérez et al., 2008 and WaaL Pa , which were identified previously (Abeyrathne and Lam, 2007) and also in this study (R212 in WaaL Pa ). B. Linear representation of the topological models in A. The numbers indicate the position of the amino acid residues in WaaL Ec (419 amino acids) and WaaL Pa (401 amino acids). Concordant TMH segments in the three models are indicated in black. TMH segments IV, V, VI, VII and VIII in WaaL Pa -Del/Fus (light gray) differ from those predicted in silico for both E. coli and P. aeruginosa WaaL proteins. the efficacy of conventional antibiotics. Elucidating the ligation mechanism is a critical step prior to the rational design of novel ligase inhibitors.
The best-studied ligases to date are the E. coli and Pseudomonas aeruginosa WaaL proteins (herein WaaL Ec and WaaL Pa , respectively) (Abeyrathne et al., 2005; Abeyrathne and Lam, 2007; Pérez et al., 2008; Islam et al., 2010; Pan et al., 2012; Ruan et al., 2012) . Both proteins have 12 transmembrane helices (TMHs) and a characteristic large periplasmic loop (PL5). Conceivably, WaaL activity involves amino acids exposed to the periplasmic space where they could interact with donor and acceptor molecules (Pérez et al., 2008; Ruan et al., 2012) . A conserved arginine residue critical for ligation, R215 in WaaL Ec , is present in the preceding short periplasmic loop PL4 (Pérez et al., 2008) . We proposed a structural model for the WaaL Ec PL5 in which arginine-288 (R288) and histidine-338 (H338), two conserved residues that are needed for efficient ligation, are exposed to the solvent in a spatial arrangement that suggests direct interactions with substrate molecules (Pérez et al., 2008) . The critical H338 residue is part of a conserved motif (H[NSQ] X 9 GX 2 [GTY]) spanning the C-terminal end of PL5 and the periplasm-membrane boundary of the TMH-X .
Structural evidence from the analysis of the WaaLcatalyzed linkage between the acceptor sugar residue at the lipid A-core and the OAg residue linked to Und-PP, together with biochemical data, suggests WaaL proteins are metal-independent inverting glycosyltransferases . Therefore, WaaL proteins should have common features, including a similar topological location of functionally relevant amino acid residues. Both WaaL Ec and WaaL Pa have relatively similar in silico-predicted membrane topologies ( Fig. 1A and B) . However, the experimental determination of the WaaL Pa topology using truncated protein derivatives arising from a deletion/reporter fusion analysis revealed striking differences with WaaL Ec (Islam et al., 2010) . While experimental data and in silico predictions agree with the topology of the N-and C-terminal regions of WaaL Pa (spanning TMH-I to TMH-III and TMH-IX to TMH-XII, respectively), major differences appear in the central region of the protein spanning TMH-IV to TMH-VIII (Fig. 1B) . These TMHs in the experimental model had no concordance with the predicted boundaries for each of the corresponding TMHs in the in-silico model ( Fig. 1A and B) . A striking difference between the two models was the presence (WaaL Pa -Del/ Fus in Fig. 1A and B) of a large cytosolic loop between amino acid residues at positions 153-182 (CL3) in the experimental model, which contained highly hydrophobic residues commonly present in TMH segments. Further, the predicted conserved essential arginine residue R212 (corresponding the R215 in Waal Ec ) was buried in TMH-VIII of the WaaL Pa -Del/Fus model, but exposed to the PL4 in the in-silico model ( Fig. 1A and B) . Intriguingly, the experimentally assigned TMH-VIII in WaaL Pa -Del/ Fus also contained three positively charged residues in tandem (arginine-231, lysine-232 and lysine-233) (Islam et al., 2010) , which would be highly unusual residues to be embedded in the lipid bilayer. In this work, we have comparatively evaluated the topology of WaaL Ec and WaaL Pa by a scanning cysteine accessibility mutagenesis (SCAM) strategy using the membrane-impermeable sulfhydryl reagent polyethylene glycol maleimide (PEG-Mal). Our experiments demonstrate that both proteins share identical topology. Further, examining the in vitro ligation reaction using purified WaaL Pa , we demonstrate that ligation occurs in the presence of EDTA, suggesting it cannot require ATP, as we previously observed for WaaL Ec , and we also provide evidence that WaaL Ec forms functional dimers. We conclude that WaaL Ec and WaaL Pa proteins are archetypes of a family of metal-independent, membrane-embedded glycosyltransferases sharing similar topology and functional properties.
Results

E. coli and P. aeruginosa WaaL proteins lacking native cysteines remain functional and both require a conserved arginine residue
To investigate the topology of WaaL Ec and WaaL Pa , we first expressed both proteins as C-terminal FLAG10xHis-tag fusions under the control of exogenous L-arabinose from a pBAD24 vector derivative (Table 1) . Protein expression was detected by immunoblot using an anti-FLAG monoclonal antibody, being optimal in the presence of 0.2% L-arabinose (Fig. S1) . A cysteine-less version of WaaL Ec (WaaL Ec C-less) was constructed by sequential site-directed replacements to alanine of each native cysteine residue in the native protein at positions 29, 54, 203 and 225. We also replaced by alanine a cysteine residue at position 428, which originated from the FLAG-tag fusion construction. Further, we generated WaaL Ec versions with a single cysteine at position 29 (WaaL Ec C29) and 428 (WaaL Ec C428), whereby the other native cysteine residues were replaced by alanine. Additional single cysteine replacements were made at selective sites.
Similarly, we constructed a cysteine-less version of WaaL Pa (WaaL Pa C-less) by replacing the native cysteine residue 114 and the Cys-403 residue originated from the FLAG-tag fusion by alanine. By replacing each cysteine residue individually, we also generated versions of WaaL Pa with single cysteines at positions 114 (WaaL Pa C114) and 403 (WaaL Pa C403). Under induction with 0.2% L-arabinose, all the mutant derivatives of (Fig. S1 ).
The cysteine-less version of WaaL Ec and all the single cysteine-alanine substitutions did not affect OAg ligation, as determined by the ability of each mutant protein to support O7 LPS surface expression in E. coli SCM3 (pJHCV32) (Fig. 4A) . This E. coli K12 strain has a chromosomal deletion that eliminates the OAg and colanic capsule synthesis gene clusters and contains also a deletion of the waaL gene (Pérez et al., 2008) , while the cosmid pJHCV32 encodes the O7 lipopolysaccharide antigen gene cluster (Valvano and Crosa, 1989) . The WaaL G286C mutant showed an apparently slight decrease in ligase activity, which could not be attributed to reduced protein expression and may be due to reduced efficiency of the enzyme.
Likewise, the cysteine-less version of WaaL Pa and most of the single cysteine substitutions restored OAg LPS surface expression in the P. aeruginosa PAO1waaL::Gm R mutant to levels comparable to those in the parental PAO1 strain (Fig. 4C) . The replacements R147C, L155C and S187C showed a small reduction in ligase function in comparison to the parental WaaL Pa , while the S169C and G282C replacements had a stronger effect since OAg in the LPS was not detected by silver staining (Fig. 4C , upper panel). To determine if the reduced ligase activity observed by OAg complementation was due to different levels of protein expression, we isolated total membranes and detected the WaaL Pa proteins by immunoblot. This experiment demonstrated that all the single Cys replacements are expressed at WaaL Pa parental levels, except for G282C in which the protein level is reduced (Fig. 4C , bottom panel). We used a more sensitive approach to determine the ligase activity of the single Cys mutants based on immunoblot with the anti-O5 monoclonal antibody (MF15-4). This experiment shows that only the G282C replacement is affected in its ability to restore OAg ligation, while all the other replacements supported OAg ligation (Fig. 4C , middle panel). A G282A replacement mutant also exhibited the same phenotype as G282C (Fig. S2 )., suggesting that the G282 residue in WaaL Pa is important for ligase function, either by being involved in the reaction or by maintaining the local conformation of a putative catalytic fold. Together, we conclude that except for WaaL Pa G282C, the cysteine-less versions of WaaL Ec and WaaL Pa , as well as their single cysteine replacement derivatives remain functional. Because the Arg-212 residue in WaaL Pa is the counterpart of Arg-215 in WaaL Ec , which is required for ligase function (Pérez et al., 2008 , we generated a WaaL Pa derivative with an alanine replacement at this site (WaaL Pa R212A). This mutant protein lost the ability to complement the ligase function in the A. Schematic description of the sulfhydryl labeling test by PEGylation. Predicted immunoblot profiles of WaaL polypeptides with single cysteine replacements based on the accessibility of the residue depending on its location and the treatment with NEM, SDS or both. The expected profiles denote residues located in the periplasm, in periplasmic/TMH borders, embedded in the TMH, in TMH/cytoplasmic borders or exposed to the cytoplasm. The structures of PEG-Mal and NEM are also indicated. B. E. coli DH5α producing plasmid-encoded Cys-substituted variants of WaaL Ec were grown at 37 o C in 5 ml of cultures to mid-exponential phase and processed as explained in Experimental Procedures. 15-µl aliquots were separated by SDS-PAGE and immunoblotted using the anti-FLAG monoclonal antibody. Modification of E. coli WaaL by PEG-Mal causes a shift in the WaaL band of ~20 kDa. M, Dual Color Precision Plus Protein standards (Bio-Rad). No PEGMal. Control experiment in HEPES buffer only. A sample from E. coli expressing the parental WaaL (WaaL Ec ) was loaded as an expression control. PEGMal. Bacterial cell suspensions were treated with 1 mM PEG-Mal and no SDS. NEM/SDS/PEGMal. Cell suspensions were first treated with 5 mM NEM and then with 1 mM PEG-Mal in the presence of 2% SDS. SDS/PEGMal. Cell suspensions were treated with 1 mM PEG-Mal in the presence of 2% SDS.
Labeling of Cys residues with PEG-Mal supports the predicted topological model of WaaL Ec
Our previous study using GFP as a topology probe and trypsin digestion determined a C-terminus inside, a large periplasmic loop PL5 and a small adjacent periplasmic loop PL4 for the E. coli K-12 WaaL, which is consistent with the predicted topology proposed by Perez et al. (Pérez et al., 2008) and with a study using oxidative labeling of Met and Cys followed by mass spectroscopy (Pan et al., 2012) . In this study, we used the substituted-cysteine accessibility method (SCAM) for mapping WaaL topology in their native state. This approach is based on the introduction of single Cys residues at various positions in a membrane protein followed by chemical modification with a membrane impermeable thiol-specific reagent, polyethylene glycol maleimide (PEG-Mal), either before or after disrupting cell membrane integrity by detergent treatment (Fig. 2A) .
The results show that WaaL Ec C-less could not be labeled by PEG-Mal in the absence or presence of SDS, or in the presence of N-ethylmaleimide (NEM), a low molecular weight, membrane permeable sulfhydryl-reactive compound that blocks PEGylation (see Experimental Procedures and Fig. 2A) , and sodium dodecylsulfate SDS (Fig. 2B) , providing a negative control for the PEGylation assay. In contrast, residue C29 neither was accessible to PEG-Mal in the absence of SDS nor could be blocked by NEM, but it was labeled by PEG-Mal in the presence of SDS (Fig. 2B) , indicating that C29 is embedded within a TMH, as we previously demonstrated by oxidative labeling (Pan et al., 2012) . The residue C428 was inaccessible to PEG-Mal in the absence of SDS, but accessible to NEM and PEG-Mal in the presence of SDS (Fig. 2B) , as expected for a residue facing the cytosol, which is consistent with the C-terminus inside topology of WaaL Ec (Pérez et al., 2008; Pan et al., 2012) .
We then examined the accessibility of residues I162, T176 and T190, which were predicted to reside in the periplasmic PL3 loop, TMH-VI and the cytoplasmic CL3 loop of WaaL Ec respectively (Fig. 1) . The counterpart of this region in the model of WaaL Pa proposed by Islam et al. (2010) exhibits a very different topology (Fig. 1) . The WaaL Ec I162C residue was accessible to PEG-Mal in the absence of SDS, but blocked by NEM and labeled by PEG-Mal in the presence of SDS (Fig. 2B) , denoting a periplasmic location. Residue T176C was not accessible to PEG-Mal in the absence of SDS, could not be blocked by NEM and could be labeled by PEG-Mal in the presence of SDS (Fig. 2B) , indicating the residue forms part of the TMH-VI. Residue T190C was consistently not labeled by PEG-Mal in the presence of SDS (Fig. 2B) , so we could not precisely localize it. This residue may be sequestered into a local secondary structure configuration that makes it inaccessible to PEG-Mal, as we have shown for other membrane proteins (Furlong et al., 2015) .
Residues T214 and A216 flank R215, a crucial residue for the WaaL Ec function (Pérez et al., 2008; Ruan et al., 2012) . Both T214C and A216C were weakly PEGylated in the presence of SDS (Fig. 2B) . Further, T214C was also labeled by PEG-Mal in the absence of SDS and blocked by NEM (Fig. 2B ), indicating this residue faces the periplasmic space. Conversely, residue A216C was not accessible to PEG-Mal in the absence of SDS, but PEGylation was blocked by NEM (Fig. 2B) , suggesting A216 is at the periplasmic border of TMH8. Together, these results support the prediction that R215 is located in a short loop exposed to the periplasm (Pérez et al., 2008; Ruan et al., 2012) . Residue G286C was accessible to PEG-Mal, both in the absence and presence of SDS, and labeling was blocked by NEM (Fig. 2B) , indicating that G286 is located in periplasm, consistent with the prediction that G286 is a residue in PL5. Together, the results from PEGylation accessibility of the single Cys mutants are consistent with the previously predicted topology of WaaL Ec (Fig. 5A) .
PEG-Mal labeling of Cys residues in P. aeruginosa WaaL validates a topological model similar to that of E. coli WaaL
As shown in Fig. 3 , WaaL Pa C-less was not labeled at any condition providing a negative control for the PEGylation assays. Residue C114 of WaaL Pa was not labeled by PEG-Mal in the presence of SDS (Fig. 3) , so we could not assign a location for this residue. Residue C403 was inaccessible to PEG-Mal in the absence of (Beitz, 2000) . The E. coli WaaL and B. P. aeruginosa WaaL topologies deduced from PEGylation experiments in this study were compared to the P. aeruginosa WaaL topology based on dual-reporter fusions (Islam et al., 2010) . PL, periplasmic loop; CL, cytoplasmic loop. TMHs are indicated in roman numerals. Residues in black squares denote TMH location. Purple diamonds indicate functional residues that when replaced by alanine abolish ligation. Methionine residues accessible by oxidation in WaaL Ec are indicated by blue squares with black letters. Residues in blue circles are exposed to the periplasmic space, while residues in red circles are exposed to the cytosol. White residues in blue square background were experimentally positioned at the TMH-periplasmic border. The C-terminal residues of WaaL Ec and WaaL Pa protein (N419 and P401, respectively), as well as the additional residues of the FLAG-10xHis tag peptides are also indicated. To better emphasize the differences between the two WaaL Pa models, the location of the residues determined by PEGylation in P. aeruginosa WaaL (revised topology) has been maintained in the P. aeruginosa WaaL model. A. Topology of WaaL Ec . B. Revised topology of WaaL Pa based on cysteine accessibility experiments using the intact protein. C. WaaL Pa topology based on dual-reporter fusions using truncated proteins (Islam et al., 2010) . SDS, weakly PEGylated with SDS, but PEGylation was blocked by NEM in the presence of SDS (Fig. 3) . This is consistent with a C-terminus inside the topology of WaaL Pa . We then examined 10 residues predicted in silico to be located in TMH-V (R147), the PL3 loop (L155, L157, T158 and G161), TMH-VI (N165, S169, A170 and A178) and in the CL3 loop (S187) (Fig. 1) . These same 10 residues were assigned to TMH-VI (R147), CL3 (L155, L157, T158, G161, N165, S169, A170 and A178) and TMH-VII (S187) in the model proposed by Islam et al. (2010) (Compare Fig. 5B and C) . The single cysteine substitutions of the 10 residues were labeled by PEGMal in the presence of SDS (Fig. 3) . Residue R147C was inaccessible to PEG-Mal in the absence of SDS and unblocked by NEM (Fig. 3) , indicating that R147 is embedded in a TMH. Residues L157C, T158C and G161C were accessible to PEG-Mal in the absence of SDS and also blocked by NEM (Fig. 3) , indicating they are exposed to the periplasm. L155C was not accessible to PEG-Mal in the absence of SDS, but accessible to PEG in the presence of SDS (Fig. 3) , indicating a location near the periplasmic border of the TMH. N165C, S169C, A170C and A178C were not accessible to PEGMal in the absence of SDS and not blocked by NEM (Fig. 3) , indicating they are part of the TMH. S187C was not accessible to PEG-Mal in the absence of SDS, but PEGylation was blocked by NEM (Fig. 3) , indicating that S187 is in the cytoplasm. The results demonstrate that the topology of WaaL Pa resembles that of WaaL Ec (Fig.  5A and B) .
Further, residues S211 and T213 flank R212, a counterpart of the functional residue R215 in the PL4 of WaaL Ec . Both WaaL Pa S211C and T213C residues were labeled by PEG-Mal in the presence of SDS (Fig. 3) . S211C was also PEGylated in the absence of SDS and accessible to NEM (Fig. 3) , indicating this residue faces the periplasm. Conversely, T213C was inaccessible to PEG-Mal in the absence of SDS but accessible to NEM (Fig. 3) , suggesting a location at the periplasmic border of TMH-VIII. These data demonstrate that R212 is also part of the short periplasmic loop PL4, in contrast to the model by Islam et al. (2010) (Fig. 5C) , in which S211, R212 and T213 are located in TMH-VIII.
We also examined six residues spanning the segment between L251 and V309, which are predicted to be located in PL5 and its borders (Fig. 5B ). All the single Cys substitutions of these residues were accessible to PEG-Mal in the presence of SDS (Fig. 3) . Residue V255C was also labeled by PEG-Mal in the absence of SDS and labeling blocked by NEM (Fig. 3) , indicating a periplasmic location (Fig. 5B) . L251C was not accessible to PEG-Mal in the absence of SDS, but PEGylation in SDS was blocked by NEM (Fig. 3) , indicating it is located at the periplasmic borders closer to the C-terminus of TMH-IX. P253C was not accessible to PEG-Mal in the absence of SDS and not blocked by NEM (Fig. 3) , also suggesting this residue may be located near the border of TMH-IX (Fig. 5C ). Residue G282C was accessible to PEG-Mal in the absence of SDS and labeling blocked by NEM (Fig. 3) , indicating a periplasmic location within PL5 (Fig. 5B) . Both L307C and V309C were not accessible to PEG-Mal in the absence of SDS and not blocked by NEM (Fig. 3) , indicating they are embedded within TMH-X. Therefore, the experimental results obtained by PEG-Mal labeling of these six residues agree with both the in silico model for WaaL Pa (Fig. 1B) and the topology proposed by Islam et al. (2010) (Fig. 1C) . Together, our experimental data demonstrate that the topology predictions by Islam et al. (2010) , which were based on deletion-fusion experiments, are not accurate to delineate the topology of the central portion of WaaL Pa (Figs. 1 and 5C) since they are not supported by PEG-Mal labeling of intact protein derivatives. Based on our results, we conclude that both WaaL Pa and WaaL Ec share a similar membrane topology, as shown in Fig. 5A and B. 
WaaL Pa exhibits similar functionality as WaaL Ec
Previous work reported that WaaL Pa required ATP hydrolysis for ligation, while this was not the case for the WaaL Ec protein (Han et al., 2012; Ruan et al., 2012) . To assess the WaaL Pa functionality, we purified this protein and performed an in vitro ligase assay, as previously described . Initial experiments using LPS ligation substrates containing a mixture of Und-PPlinked O-polysaccharides (including A-band homopolysaccharide and B-band heteropolysaccharide) and LPS C. Oligomerization analysis of purified WaaL and WaaLC-less after treatment with the DSP cross-linker (5mM) and under reducing conditions (DTT). Samples were processed for SDS-PAGE and immunoblotting with anti-His antibody. WaaL forms protein complexes that are not present when incubated with DTT or weakly formed in the C-less version. In non-reducing conditions, a monomeric, a dimeric form (**) and multimeric forms (****) were visible. core were prepared from PAO1waaL::Gm R and mixed with purified WaaL Pa did not result in ligation products that were detectable by silver staining. P. aeruginosa produces two forms of lipid A-core. One of them consists of a capped core in which an L-rhamnose is attached to a terminal glucose (glucose-I) by WapR, while the other (uncapped core) contains L-rhamnose attached to glucose-II by MigA (Kocincova and Lam, 2011) . From these two core forms, only the capped core is a substrate for ligation with O-antigen polysaccharide. To increase the proportion of capped core, we constructed pXR93, overexpressing WapR under the control of the lac promoter. The strategy of preparing the ligation substrates from the P. aeruginosa strain PAO1waaL::Gm R (pXR93) expressing the WapR protein allowed us to detect LPS products by silver staining (Fig. 6) (Fig. 6 , Lane 9). This indicated that, as in the in vitro ligase assay for WaaL Ec , WaaL Pa is also an ATP hydrolysis-independent, metal ion-independent glycosyltransferase .
Ligation results in inversion and is specific for the lipid A core substrate
Structural data on LPS of many different species revealed a β-linkage of the sugar from the OAg unit attached to the terminal lipid A-core acceptor site. Interestingly, this sugar is also the one proximal to Und-PP, which arises from the diphosphate nucleotide sugar precursors in the α-configuration employed in the initiation reaction by enzymes of the WecA and WbaP families (Valvano, 2011; Ruan et al., 2012) , indicating WaaL is an inverting glycosyltransferase . To gather additional evidence for this mechanism, we examined the reactivity of chemically characterized E. coli lipid A-core forms with a monoclonal antibody specific to β-O-linked N-acetylglucosamine (β-O-GlcNAc). For this experiment, we employed LPS from different E. coli strains (Fig. 7 ). W3110 has a lipid A-core with a terminal β-linked-GlcNAc, which results from the synthesis of a truncated O-antigen unit consisting of Und-PP-GlcNAc (Feldman et al., 1999) . CLM35, a strain with wecA and wzx double deletion, produces lipid A-core devoid of GlcNAc (Marolda et al., 2006b) . The LPS from CLM24, a strain with waaL deletion, contains a mixture of lipid A-core and Und-PP-GlcNAc (Feldman et al., 2005) , while CLM24(pXR1) contains the plasmid pXR1 expressing E.
coli WaaL and therefore producing lipid A-core with a terminal GlcNAc residue (Fig. 7A ). The strain F632 is an E. coli R2 chemotype bacterium producing a lipid A-core with a terminal α-linked-GlcNAc (Leipold et al., 2007) . While the LPS preparations looked similar by silver staining, only those from W3110 and CLM24(pXR1) reacted with the anti-β-O-GlcNAc antibody (Fig. 7A) , confirming that the terminal GlcNAc attached to K-12 LPS core is in β-configuration. The absence of a positive signal with the antiserum in the F632 LPS shows that the antiserum cannot detect GlcNAc in the α-configuration. These results provide additional support to the notion that WaaL is an inverting glycosyltransferase. Another property of the ligase is its specificity for the terminal core acceptor site, which was determined by genetic experiments (Heinrichs et al., 1998a (Heinrichs et al., ,1998b (Heinrichs et al., ,1998c . We took advantage of the in vitro ligation assay to determine in vitro if the WaaL Ec can ligate O-antigen substrates from different bacterial species. We used four LPS preparations containing lipid A-core and endogenously made Und-PP-linked O-antigen substrates (Fig. 7B) . They included LPS from strain CLM35 (Core Ec ) containing lipid A-core plus Und-PP-GlcNAc, LPS from strain CLM24(pMF19) (LPS Ec ) containing lipid A-core plus Und-PP-OAg, LPS from strain PAO1waaL::Gm R (pXR93) (LPS Pa ) containing lipid A-core core plus Und-PP-OAg (from P. aeruginosa) and lipid A-core from strain K56-2waaL Bc ::pGPΩTp (LPS Bc ) containing lipid A-core plus Und-PP-OAg (from Burkholderia cenocepacia). We mixed purified WaaL Ec with different combination of the LPS preparations as described in Experimental Procedures. Our results show that LPS preparations from P. aeruginosa (LPS Pa ) and B. cenocepacia (LPS Bc ) enriched for Und-PP-linked O antigen result in the production of E. coli lipid A-core with the ligated O-polysaccharides from the respective species (Fig. 7B , Lane 5 and 7C, Lane 6, respectively), as efficient as LPS preparation from E. coli (LPS Ec ) (Fig . 7B, Lane 6) . From these experiments, we conclude WaaL lacks specificity of the Und-PP-linked OAgs.
E. coli WaaL forms functional oligomers
Purified E. coli and P. aeruginosa WaaL preparations typically show variable amounts of larger products in SDS-polyacrylamide gel electrophoresis (PAGE) that react with the anti-FLAG antibody suggesting the presence of multimeric forms of the protein samples (Fig.  S1 ) likely due to incomplete denaturation since heating at 100°C in SDS precludes detection of polytopic membrane proteins in SDS-PAGE (Marolda et al., 2004; Vinés et al., 2005; Abeyrathne and Lam, 2007; Lehrer et al., 2007; Tatar et al., 2007; Pérez et al., 2008; Ruan et al., 2012) . However, these larger forms could also occur by dimerization. To investigate if WaaL can form functional dimers, we reasoned that constructs lacking ligase function when expressed singly could revert to functional enzyme forms when expressed jointly. To explore this possibility, we used WaaL Ec functionally defective constructs that exhibited observable protein expression, but could potentially restore ligation if jointly expressed. These included WaaLΔN2TM , a derivative of WaaL Ec with a deletion removing amino acid residues from Leu-2 to Asn-71 and eliminating TMHs I and II, WaaL-R288A and WaaL-R215A . All these recombinant proteins, expressed from pBAD24 in the presence of L-arabinose, were detected by immunoblot at comparable levels (Fig. 8A, left panel) . Similarly, WaaLΔN2TM expressed from pBAD33, a plasmid that is compatible with the pBAD24 (Guzman et al., 1995) , was also readily detected by immunoblot (Fig. 8A,  right panel) . We first confirmed that the recombinant WaaL proteins function in vivo as expected. For this we transformed the E. coli SCM3(pJHCV32) with various plasmids encoding each of the WaaL proteins and examined the production of O7 polysaccharide. Fig. 8B , left panel, shows that no O7 polysaccharide was produced in the presence of WaaLΔN2TM , WaaL-R288A and WaaL-R215A. In contrast, O7 polysaccharide was detected in SCM3(pJHCV32) bacteria expressing the parental WaaL and WaaL R215K , as expected from previous results showing that a positively charged amino acid is required at position 215 of E. coli WaaL (Pérez et al., 2008; Ruan et al., 2012) . Next, we co-expressed each of these proteins with WaaLΔN2TM, which was expressed from pBAD33. The results revealed that O7 polysaccharide was produced by co-expression of WaaLΔN2TM/ WaaL-R288A or WaaLΔN2TM/WaaL-R215A (Fig. 8, right  panel) , indicating that the reversal of the ligase function could originate from protein-protein interactions between WaaLΔN2TM and WaaL-R288A, or between WaaLΔN2TM and WaaL-R215A.
We also investigated WaaL oligomerization by chemical cross-linking. The E. coli WaaL and WaaLC-less proteins with FLAG and 10xHis tags were purified from E. coli JM105v, as described previously . The membrane-permeable cross-linker dithiobis (succinimidylpropionate) (DSP) was used, which cross-links molecules whose respective lysine residues come within 12.0 Å, the spacer length of the cross-linker (Smith et al., 2011) . Extensive cross-linking of WaaL was apparent by anti-His immunoblot. A portion of each sample was treated with the reducing agent dithiothreitol (DTT) to cleave the cross-linking. The results show that WaaL Ec forms oligomeric species of higher apparent mass in the presence of DSP, while the monomeric protein is efficiently recovered by addition of DTT (Fig. 8C,) . To investigate if dimerization involves disulfide bond formation, we also performed cross-linking experiments with the WaaLC-less protein. The results show that native cysteines are partially involved in dimerization, as cross-linking was less efficient with the cysteine-less protein (Fig. 8C) . Therefore, the genetic reconstitution experiments and biochemical cross-linking data indicate WaaL can form oligomers and is likely a functional dimer in vivo.
Discussion
Using a SCAM strategy based on PEGylation, we show here that the topologies of E. coli and P. aeruginosa WaaL proteins are highly similar. The WaaL Pa topology model we constructed differs from that previously reported in the literature, which was based on a dual-reporter fusion approach (Alexeyev and Winkler, 1999) and resulted in a library of truncated versions of WaaL Pa C-terminally fused to reporter β-galactosidase and alkaline phosphatase enzymes for determining the cytoplasmic or periplasmic location of each fusion end point respectively (Islam et al., 2010) . Reporter fusions are commonly used to map the topology on membrane proteins, but the strategy is not devoid of pitfalls, especially considering that the topogenic signals for membrane protein insertion depend on both amino acid and membrane lipid compositions (Bogdanov and Dowhan, 1999) . Indeed, the dual-reporter fusion strategy for WaaL Pa did not accurately predict TMHs and loops boundaries in the central region of the protein. This could most likely be caused by disruption of TMH-TMH interactions leading to alternative topologies of the truncated WaaL segment included in the fusion. Similar observations were made for TMH-I of the E. coli α-ketoglutarate permease, which was not detected by a PhoA fusion owing to the presence of positively charged residues in other TMH domains that were required to neutralize the negatively charged residues in TMH-I, facilitating its membrane insertion (Seol and Shatkin, 1993) . Alternatively, truncated TMH domains may form helical hairpins that result in the mislocalization of the reporter protein (Cassel et al., 2008) .
SCAM is also not free of drawbacks, as residues in certain locations may become inaccessible to sulfhydryl labeling (Bogdanov et al., 2010) . We noted that the cysteine replacement at position 190 in WaaL Ec (T190C) could not be labeled under any of the conditions tested. This residue, presumably located in the CL3, is flanked by a tyrosine residue at one end and two lysine residues at the other end, suggesting the possibility of a local secondary structure stabilized by salt bridges between the tyrosine and the lysine residues, which would prevent the access of PEG-Mal by steric hindrance. Local secondary structure preventing access of PEG-Mal was noted before in the TMH-V of membrane protein WcaJ, which does span the membrane and forms a hairpin helix around a proline and a serine residue (Furlong et al., 2015) . Similarly, the native cysteine residue at position 114 of WaaL Pa could not be labeled. This residue is predicted to be embedded in TMH-IV, and lack of labeling with PEG-Mal in this case could arise from the absence of ionization of the thiol group within a strong hydrophobic environment (Bogdanov et al., 2010) . However, despite the difficulties with the localization of these specific residues, the overall topology of WaaL Pa derived from PEG-Mal SCAM agrees with that of WaaL Ec . Indeed, the critical residues for ligase function in both proteins, Arg-215 in WaaL Ec and Arg-212 in WaaL Pa are orientated toward the periplasmic space within a short PL4 region. This is consistent for a protein that requires access to substrates in the periplasmic space.
Further, our in vitro ligation experiments demonstrated that the WaaL Pa -catalyzed ligation occurs in the presence of high concentration of the metal divalent ion chelator EDTA, indicating that the reaction is metal cation independent, which also rules out an involvement of ATP hydrolysis, as previously reported (Abeyrathne and Lam, 2007) . Therefore, we conclude that WaaL Pa has the same general properties of previously characterized ligases such as those from E. coli K-12 , E. coli O86 (Han et al., 2012) and Helicobacter pylori (Hug et al., 2010) , displaying similar membrane topology and biochemical function.
In a previous study, we suggested the WaaL Ec is an inverting glycosyltransferase . This means the glycosyl bond formed by the ligation reaction has an inverted anomeric configuration with respect to the donor substrate (Lairson et al., 2008) . The substrate for the ligase reaction is the Und-PP-linked proximal sugar, which in turn is the product of the initiation reaction resulting in the formation of a phosphoanhydride bond without a change in the anomerization of the sugar backbone structure (Valvano, 2011) . Indeed, the diphosphate nucleotide sugar precursors for the initiation reaction, such as UDP-Gal, UDP-Glc and UDP-GlcNAc, are all in α-configuration (Murazumi et al., 1979; Weisgerber and Jann, 1982; Olsthoorn et al., 2000) . In this work, we provide additional evidence for inversion of anomerization upon ligation by showing that a single GlcNAc residue ligated to E. coli K-12 lipid A-core reacted with an anti-β-O-GlcNAc antibody, confirming that this residue is in the β-configuration.
Several cytoplasmic membrane proteins implicated in the assembly of cell surface polysaccharides form oligomeric structures (Collins et al., 2017; Liston et al., 2015; Whitfield and Trent, 2014) . Further, the MraY protein that initiates cell wall peptidoglycan synthesis forms dimers both in detergent micelles and in the membrane (Chung et al., 2013) . To probe whether WaaL can form oligomers in vivo, we employed a genetic reconstitution strategy by co-expressing an N-terminally truncated WaaL Ec version that contains intact functional residues in PL4 and PL5 regions with an intact WaaL Ec with single substitutions in functional amino acids. This experiment resulted in the restoration of O-antigen synthesis, which was not possible with any of these proteins when expressed individually. Oligomerization of WaaL Ec was independently supported by chemical cross-linking analyses, suggesting this protein adopts a functional oligomeric form in the membrane.
Together, this study demonstrates that WaaL Ec and WaaL Pa proteins share similar topology and functionality, indicating that O-antigen ligases have conserved features consistent with their function at the periplasmic side of the membrane and pointing out to a common glycosyl transfer mechanism.
Experimental Procedures
Bacterial strains, plasmids and growth conditions
Strains and plasmids used in this study are listed in Table  1 . Bacteria were cultured at 37 o C in a Luria-Bertani (LB) medium supplemented with ampicillin (100 µg ml -1 ), tetracycline (20 µg ml -1 ), chloramphenicol (30 µg ml -1 ) for E. coli, or with tetracycline (100 µg ml -1 ), gentamicin (30 µg ml -1 ) for P. aeruginosa or with 0.2% (w/v) L-arabinose, when appropriate.
Construction of strains and plasmids
P. aeruginosa genomic knockout mutants PAO1waaL:: Gm R were constructed for complementation. The waaL gene of the P. aeruginosa strain PAO1 was amplified from genomic DNA by PCR using forward primer 5368 and reverse primer 5369 (Table S1) , and cloned into pEX18Tc vector, followed by inserting a gentamicin-resistance cassette into SalI site within the waaL gene, producing the insertional mutant PAO1waaL::Gm R . This construct was transformed into PAO1 by electroporation, and transformants plated on LB + 100 µg ml -1 of tetracycline. waaL knockout mutants were selected by subsequent plating on 5% sucrose agar plates containing 30 µg ml -1 of gentamicin. For complementation experiments, the PAO1 waaL gene was subcloned from pXR14, pXR23 and all pXR23 and pJM plasmids with single cysteine substitution mutants by digesting with EcoRI and HindIII, and ligating it into pUCP26, also digested with the same restriction enzymes. The wapR gene of PAO1 was amplified from the genomic DNA by PCR using forward primer 7049 and reverse primer 7050 (Table S1) , and the amplicon digested with EcoRI and PstI and ligated to pUCP26, which was also digested with the same restriction enzymes, yielding plasmid pXR93.
The E. coli waaL ΔN2TM , which carries a deletion eliminating amino acids Leu-2 to Asn-71, was amplified from pXR1 using primers 5995 and 5730 (Table S1) , and the amplicon digested with EcoRI and PstI was ligated to pBADFLAG, which was also digested with the same restriction enzymes, yielding plasmid pXR39. This strategy deletes the complete WaaL encoding sequence and allows replacement with the truncated one. To generate pXR76, encoding E. coli waaLΔN2TM in pBAD33, both pXR39 and pBAD33 were digested with ClaI and HindIII, and the 2.7 Kb insert was ligated to the 4-Kb fragment from pBAD33. All replacements were verified by DNA sequencing.
Site-directed mutagenesis
pXR1, encoding a C-terminal FLAG followed by 10xHis-tagged E. coli WaaL, was used as a DNA template for site-directed mutagenesis to construct pXR36, encoding cysteine-less E. coli WaaL. pXR36 was then used as a DNA template for site-directed mutagenesis to construct E. coli WaaL mutants with single cysteine replacements. pXR14, encoding a C-terminal FLAG followed by 10xHis-tagged P. aeruginosa WaaL, was used as a DNA template for site-directed mutagenesis to construct pXR23, encoding cysteine-less P. aeruginosa WaaL. pXR23 was then used as a DNA template for site-directed mutagenesis to construct P. aeruginosa WaaL mutants with single cysteine replacements. The Cys-428 codon in E. coli WaaL and Cys-403 codon in P. aeruginosa WaaL do not exist in the native gene, but from the construction of FLAG-tag. pXR14 was also used as a DNA template for site-directed mutagenesis to construct P. aeruginosa WaaL-R212A. Table  S1 of supplementary data shows the DNA sequences of all primers used for mutagenesis. Pfu polymerase was used in PCR amplification for site-directed mutagenesis. The PCR products were digested overnight with 1 U DpnI at 37 o C, and then introduced into E. coli DH5α competent cells by transformation. Ampicillin-resistant colonies were screened. All substitutions were confirmed by DNA sequencing.
Sulfhydryl Labeling
Overnight cultures of DH5α cells containing the appropriate plasmids (Table 1) supplemented with 100 µg ampicillin ml -1 were diluted in LB medium (5 ml) to an OD 600 of 0.02. When the OD 600 reached around 0.6, protein expression was induced with 0.2% (w/v) L-arabinose. After a 2.5 h induction, the OD 600 for each culture was measured and adjusted to 0.5 with LB medium. Then, 2 ml of each adjusted culture was centrifuged at 16,000 x g for 1 min, washed twice with 4-[2-hydroxyethyl]-1-piperazineethanesulfonic acid (HEPES) buffer (50 mM HEPES [pH6.8], 5 mM MgCl 2 ) and re-suspended in 0.2 ml of the same buffer, which is referred to as '0.2 ml cell suspension' as below. For protein expression controls, the 0.2 ml cell suspension was added to 0.1 mg ml -1 lysozyme and 25 µg ml -1
DNaseI, incubated at 37 o C for 20 min and then mixed with protein loading dye for SDS-PAGE on 14% acrylamide gels. For sulfhydryl labeling with Polyethyleneglycol maleimide (PEG-Mal, 5 KDa, Sigma), each of the 0.2 ml cell suspension was incubated with 5 mM EDTA at room temperature for 10 min (+PEG-Mal) or 0.2% (w/v) SDS at 37 o C for 5 min (+SDS/+PEG-Mal), and then incubated with 1 mM PEG-Mal at room temperature for 1 h. Samples were quenched with 45 mM DTT for 10 min. Then the samples were treated with lysozyme and DNaseI before SDS-PAGE as mentioned above. For PEG-Mal labeling in the presence of N-ethylmaleimide (NEM, Sigma), each of the 0.2 ml cell suspension was incubated with 5 mM NEM at room temperature for 30 min (+NEM/+SDS/+PEG-Mal), and centrifuged at 16,000 x g for 1 min. Pellets were washed twice with the HEPES buffer, and re-suspended in 0.2 ml of the same buffer. Samples were then incubated with 2% (w/v) SDS at 37 o C for 5 min and with 1 mM PEGMal at room temperature for 1 h, and quenched with 45 mM DTT for 10 min. Then the samples were treated as mentioned above for SDS-PAGE.
Purification of WaaL proteins and in vitro ligase assay
The E. coli and P. aeruginosa WaaL proteins with FLAG and 10xHis tags were purified from E. coli JM105v as described previously . LPS was prepared as described previously (Marolda et al., 2006a) . In the in vitro ligase assay for WaaL Pa , the LPS from PAO1waaL::Gm R (pXR93) expressing WapR in the absence or presence of IPTG (0-1 mM) contains both substrates for the reaction. The in vitro ligase assay for WaaL Pa was performed using 6 µl of LPS and purified P. aeruginosa WaaL (1 µM) in 50 mM phosphate buffer at pH 7.0 in 60 µl reaction volume, and the mixture was incubated at The upper aqueous phase was collected and analyzed by Tricine-SDS-PAGE. The in vitro ligase assay for WaaL Ec was processed as described previously .
LPS and protein analysis
LPS samples were separated on 14% (w/v) Tricine-SDS-PAGE and the gels stained with silver nitrate (Marolda et al., 2006a) . For immunoblot to detect β-O-linked N-acetylglucosamine, samples in the polyacrylamide gel were transferred to nitrocellulose membranes and reacted with O-GlcNAc Monoclonal Antibody (IgM) (Covance) at a 1:1000 dilution. For O-antigen detection, anti-O5 antigen monoclonal antibody MF15-4 (Antibodies-online) was used at a 1:10,000 dilution. Alexa Fluor® 680 Goat Anti-Mouse IgM (Invitrogen) or IRDye® 800CW Goat antiMouse IgG (LI-COR) were used as secondary antibodies. For protein analysis, polyacrylamide gels were transferred onto nitrocellulose membranes, which were blocked with 10% Western Blocking Solution (Roche Diagnostics). Membranes were incubated overnight at 4 o C with anti-FLAG M2 monoclonal Antibody (Sigma) at a 1:5000 dilution or anti-His (Sigma) at a 1:10,000 dilution. IRDye® 800CW Goat anti-Mouse IgG (LI-COR) or Alexa Fluor® 680 Goat anti-mouse immunoglobulin G (IgG) (Invitrogen) were used as secondary antibodies. Reacting bands were detected by fluorescence with an Odyssey infrared imaging system (Li-cor Bioscience, Lincoln, NE).
Topology prediction
The membrane topology of WaaL proteins was assessed by TMHMM (Sonnhammer et al., 1998) and graphically displayed using Textopo (Beitz, 2000) .
Chemical cross-linking
The E. coli WaaL and WaaLC-less proteins with FLAG-His tags were purified from E. coli as described previously . Cross-linking was performed using dithiobis [succinimidyl propionate] (DSP) following manufacturer´s instructions (Thermo Scientific). DSP was prepared as a 25 mM solution in DMSO and mixed with purified protein (in PBS) to a 5 mM final concentration. The mix was incubated for 45 min at room temperature. The reaction was stopped by adding the quenching solution (50 mM TrisHCl pH 7.5) and incubated for 15 min. To cleave DSP, DTT was added at 50 mM final concentration and incubated at 37°C for 30 min. Samples were separated on 12.5% SDS-PAGE, using a loading buffer without DTT. Samples in the polyacrylamide gel were transferred to nitrocellulose membranes and incubated overnight with anti-His (Sigma) monoclonal antibody and IRDye® 800CW Goat anti-Mouse IgG (LI-COR) was used as secondary antibody. Reacting bands were detected by an Odyssey infrared imaging system (Li-cor Bioscience, Lincoln, NE).
